{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:06:22Z","timestamp":1785528382756,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05697-y","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:48:07Z","timestamp":1766573287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uterine leiomyosarcoma diagnostic challenges in a resource-limited setting: a case report and review of the literature"],"prefix":"10.1186","volume":"19","author":[{"given":"Nigat Amsalu","family":"Addis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinfemicheal Tilahun","family":"Yigzaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethlehem Aliye","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girma Damtew","family":"Adisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkam Feleke","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misganaw Abere","family":"Worku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meseret Hussen","family":"Shibesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Shiferaw","family":"Yigezaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"4","key":"5697_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0976-7800.145175","volume":"5","author":"K Kaur","year":"2014","unstructured":"Kaur K, et\u00a0al. Uterine leiomyosarcoma: a case report. J Mid-life Health. 2014;5(4):202\u20134.","journal-title":"J Mid-life Health"},{"issue":"2","key":"5697_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","volume":"36","author":"S George","year":"2018","unstructured":"George S, et\u00a0al. Soft tissue and uterine leiomyosarcoma. J Clin Oncol. 2018;36(2):144\u201350.","journal-title":"J Clin Oncol"},{"key":"5697_CR3","unstructured":"Mangla A, Yadav U. Cancer, leiomyosarcoma. Treasure Island, FL, StatPearls, 2020."},{"issue":"1","key":"5697_CR4","first-page":"161","volume":"25","author":"TM Benti","year":"2021","unstructured":"Benti TM, et\u00a0al. Recurrent vaginal epithelioid leiomyosarcoma; a case report from Botswana and review of the literature. Afr J Reprod Health. 2021;25(1):161\u20138.","journal-title":"Afr J Reprod Health"},{"issue":"3","key":"5697_CR5","first-page":"523","volume":"17","author":"AA Adewole","year":"2022","unstructured":"Adewole AA, et\u00a0al. Cervical leiomyosarcoma in a teenage girl: a rare form of uterine leiomyosarcoma. J Taibah Univ Med Sci. 2022;17(3):523\u20138.","journal-title":"J Taibah Univ Med Sci"},{"key":"5697_CR6","unstructured":"Memarzadeh S, Berek J. Uterine sarcoma: classification, epidemiology, clinical manifestations, and diagnosis. 2024; Available from: https:\/\/www.uptodate.com\/contents\/uterine-sarcoma-classification-epidemiology-clinical-manifestations-and-diagnosis?search=uterine%20liomypsarcoma&topic."},{"key":"5697_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-1596-7-85","volume":"7","author":"S Corcoran","year":"2012","unstructured":"Corcoran S, et\u00a0al. Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature. Diagn Pathol. 2012;7:1\u20135.","journal-title":"Diagn Pathol"},{"issue":"6","key":"5697_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U","volume":"19","author":"HJ Norris","year":"1966","unstructured":"Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer. 1966;19(6):755\u201366.","journal-title":"Cancer"},{"issue":"1","key":"5697_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","volume":"145","author":"S Ricci","year":"2017","unstructured":"Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145(1):208\u201316.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5697_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","volume":"93","author":"SE Brooks","year":"2004","unstructured":"Brooks SE, et\u00a0al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999. Gynecol Oncol. 2004;93(1):204\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5697_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cncr.11484","volume":"98","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98(1):176\u201386.","journal-title":"Cancer"},{"issue":"3","key":"5697_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","volume":"151","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562\u201372.","journal-title":"Gynecol Oncol"},{"key":"5697_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-1947-4-222","volume":"4","author":"VS Vellanki","year":"2010","unstructured":"Vellanki VS, et\u00a0al. A rare case of uterine leiomyosarcoma: a case report. J Med Case Rep. 2010;4:1\u20133.","journal-title":"J Med Case Rep"},{"key":"5697_CR14","doi-asserted-by":"crossref","unstructured":"Robboy SJ, et\u00a0al. Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect, 2000: p. 779\u2013784.","DOI":"10.1289\/ehp.00108s5779"},{"key":"5697_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S218222","author":"S Cao","year":"2019","unstructured":"Cao S, et\u00a0al. A case report of uterine leiomyosarcoma. OncoTargets Ther. 2019. https:\/\/doi.org\/10.2147\/OTT.S218222.","journal-title":"OncoTargets Ther"},{"issue":"1","key":"5697_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000080283","volume":"67","author":"S Sagae","year":"2004","unstructured":"Sagae S, et\u00a0al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology. 2004;67(1):33\u20139.","journal-title":"Oncology"},{"issue":"9","key":"5697_CR17","first-page":"1535","volume":"20","author":"Y Jin","year":"2010","unstructured":"Jin Y, et\u00a0al. Clinical characteristics of endometrial stromal sarcoma from an academic medical hospital in China. Int J Gynecol Cancer. 2010;20(9):1535\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"5697_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ygyno.2008.02.026","volume":"110","author":"N Bansal","year":"2008","unstructured":"Bansal N, et\u00a0al. The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol. 2008;110(1):43\u20138.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5697_CR19","first-page":"e62087","volume":"16","author":"B Mohammed","year":"2024","unstructured":"Mohammed B, et\u00a0al. Uterine leiomyosarcoma in a 22-Year-Old young woman: a case report. Cureus. 2024;16(6):e62087.","journal-title":"Cureus"},{"issue":"01","key":"5697_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.15212\/RADSCI-2024-0001","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang Y, et\u00a0al. CT diagnosis of uterine leiomyosarcoma: a case report. Radiology Science. 2024;3(01):32\u20136.","journal-title":"Radiology Science"},{"key":"5697_CR21","unstructured":"Food U, Administration D. US Food and drug administration. Birth Control: medicines to help you. 2017. p. 4. https:\/\/www.fda.gov\/forconsumers\/byaudience\/forwomen\/freepublications\/ucm313215.htm. Accessed."},{"key":"5697_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10397-015-0894-4","volume":"12","author":"EA Pritts","year":"2015","unstructured":"Pritts EA, et\u00a0al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg. 2015;12:165\u201377.","journal-title":"Gynecol Surg"},{"issue":"1","key":"5697_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00001703-199507010-00008","volume":"7","author":"BJ Quade","year":"1995","unstructured":"Quade BJ. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol. 1995;7(1):35\u201342.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"5697_CR24","unstructured":"Kurma RJ. \u201cPathology of the female genital tract,\u201d 4th edition, Springer-Verlag; New York. 2001; p. 499. 4th: [Available from: Kurma RJ. Pathology of the Female Genital Tract, 4th, Springer Verlag, New York."},{"issue":"6","key":"5697_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18(6):535\u201358.","journal-title":"Am J Surg Pathol"},{"key":"5697_CR26","unstructured":"Silverberg SG. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology, 1992: p. 181\u2013190."},{"issue":"3","key":"5697_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","volume":"89","author":"RL Giuntoli II","year":"2003","unstructured":"Giuntoli RL II, et\u00a0al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy\u2606. Gynecol Oncol. 2003;89(3):460\u20139.","journal-title":"Gynecol Oncol"},{"key":"5697_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00432-008-0422-2","volume":"134","author":"J-Y Park","year":"2008","unstructured":"Park J-Y, et\u00a0al. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989\u20132007. J Cancer Res Clin Oncol. 2008;134:1277\u201387.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"5697_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ygyno.2003.10.044","volume":"92","author":"TA Dinh","year":"2004","unstructured":"Dinh TA, et\u00a0al. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990\u20131999) at the Massachusetts General Hospital. Gynecol Oncol. 2004;92(2):648\u201352.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5697_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0020-7292(94)90164-3","volume":"45","author":"B Goff","year":"1994","unstructured":"Goff B, et\u00a0al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Int J Gynaecol Obstet. 1994;45(2):203\u2013203.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"5697_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.23245","volume":"112","author":"DS Kapp","year":"2008","unstructured":"Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112(4):820\u201330.","journal-title":"Cancer"},{"issue":"2","key":"5697_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ygyno.2003.10.043","volume":"92","author":"J Sandruck","year":"2004","unstructured":"Sandruck J, et\u00a0al. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature. Gynecol Oncol. 2004;92(2):701\u20134.","journal-title":"Gynecol Oncol"},{"key":"5697_CR33","unstructured":"Edition S, Edge S, Byrd D. AJCC cancer staging manual. AJCC cancer staging manual, 2017."},{"issue":"6","key":"5697_CR34","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","volume":"44","author":"N Reed","year":"2008","unstructured":"Reed N, et\u00a0al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer. 2008;44(6):808\u201318.","journal-title":"Eur J Cancer"},{"issue":"3","key":"5697_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ygyno.2008.11.027","volume":"112","author":"ML Hensley","year":"2009","unstructured":"Hensley ML, et\u00a0al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol. 2009;112(3):563\u20137.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"5697_CR36","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.1985.3.9.1240","volume":"3","author":"GA Omura","year":"1985","unstructured":"Omura GA, et\u00a0al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol. 1985;3(9):1240\u20135.","journal-title":"J Clin Oncol"},{"issue":"8","key":"5697_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/cncr.27942","volume":"119","author":"ML Hensley","year":"2013","unstructured":"Hensley ML, et\u00a0al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Cancer. 2013;119(8):1555\u201361.","journal-title":"Cancer"},{"issue":"2","key":"5697_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0959-8049(11)70129-0","volume":"47","author":"P Pautier","year":"2011","unstructured":"Pautier P, et\u00a0al. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas. Results on 81 randomized patients. Eur J Cancer. 2011;47(2):15.","journal-title":"Eur J Cancer"},{"key":"5697_CR39","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology. Uterine cancer. 2023; Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf."},{"issue":"3","key":"5697_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/cncr.26333","volume":"118","author":"O Zivanovic","year":"2012","unstructured":"Zivanovic O, et\u00a0al. A nomogram to predict postresection 5\u2010year overall survival for patients with uterine leiomyosarcoma. Cancer. 2012;118(3):660\u20139.","journal-title":"Cancer"},{"issue":"791","key":"5697_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1259\/0007-1285-66-791-1009","volume":"66","author":"E Moskovic","year":"1993","unstructured":"Moskovic E, et\u00a0al. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol. 1993;66(791):1009\u201315.","journal-title":"Br J Radiol"},{"issue":"2","key":"5697_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ygyno.2005.01.041","volume":"97","author":"S Kanjeekal","year":"2005","unstructured":"Kanjeekal S, et\u00a0al. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol. 2005;97(2):624\u201337.","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05697-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:48:09Z","timestamp":1766573289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-025-05697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05697-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The case report has been submitted to the School of Medicine at University of Gondar for Ethical Board Review and approved as morally sound report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of the case report and accompanying images. A copy of the written consent is available for review for the editor-in-chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"642"}}